Hemington Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$33K Buy
123
+15
+14% +$4.1K ﹤0.01% 477
2025
Q2
$27K Buy
108
+1
+0.9% +$239 ﹤0.01% 521
2025
Q1
$23K Buy
107
+25
+30% +$5.84K ﹤0.01% 544
2024
Q4
$18K Buy
82
+14
+21% +$3.37K ﹤0.01% 585
2024
Q3
$16K Buy
+68
New +$15.2K ﹤0.01% 577

Other funds holding RMD

Hemington Wealth Management's RMD Position: Q3 2025 in Review

Hemington Wealth Management increased its ResMed (RMD) stake by 14% in Q3 2025, buying an estimated $4.1K and bringing the position to 123 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

Hemington Wealth Management first reported a position in RMD in Q3 2024 and has held it in 5 quarters since. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Hemington Wealth Management held 123 shares of ResMed worth $33K as of Q3 2025.
  • Hemington Wealth Management bought 15 ResMed shares in Q3 2025, an estimated $4.1K.
  • ResMed made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #477 holding.
  • Hemington Wealth Management first reported a position in ResMed in Q3 2024 and has held it in 5 quarters since.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.